US Stock MarketDetailed Quotes

GPCR Structure Therapeutics

Watchlist
  • 27.060
  • +0.080+0.30%
Close Jan 17 16:00 ET
  • 27.390
  • +0.330+1.22%
Post 20:01 ET
1.55BMarket Cap-14.01P/E (TTM)

Structure Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Structure Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Structure Therapeutics Earnings Reports

  • Structure Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13, 2024 22:32 ET

  • Structure Therapeutics | 8-K: Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights First patients dosed in Phase 2b ACCESS study of GSBR-1290 for obesity

    Nov 13, 2024 16:17 ET

  • Structure Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 16:40 ET

  • Structure Therapeutics | 8-K: Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights

    Aug 8, 2024 16:21 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Hutchmed (China)
    HCM
    +6.61%
    Ermenegildo Zegna NV
    ZGN
    +2.34%
    New Fortress Energy
    NFE
    +2.32%
    Enerpac Tool
    EPAC
    +1.91%
    eBay
    EBAY
    +1.74%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 19, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Weight Loss Drugs
    Weight Loss Drugs
    Intraday-3.55%